Precision Biosciences is a clinical-stage gene editing company utilizing its proprietary ARCUS platform to develop in vivo gene editing therapies. Key programs include PBGENE-HBV (chronic hepatitis B, Phase 1/2a ELIMINATE-B trial), PBGENE-DMD (Duchenne muscular dystrophy, Phase 1/2 FUNCTION-DMD study), and PBGENE-3243 (mitochondrial disease, paused). The company also licenses ARCUS technology to partners including iECURE, TG Therapeutics, Imugene, and Novartis, and has licensed cell therapy patent families to Caribou Biosciences.
Q2 FY2026 — expected 2026-09-06
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-12 | 2025-12-31 | 0001628280-26-017019 | EDGAR | 105K words |
| 2025-03-26 | 2024-12-31 | 0000950170-25-044775 | EDGAR | 112K words |
| 2024-03-27 | 2023-12-31 | 0000950170-24-036817 | EDGAR | 109K words |
| 2023-03-09 | 2022-12-31 | 0000950170-23-006838 | EDGAR | 113K words |
| 2022-03-15 | 2021-12-31 | 0001564590-22-010222 | EDGAR | — |
| 2021-03-18 | 2020-12-31 | 0001564590-21-014005 | EDGAR | — |
| 2020-03-10 | 2019-12-31 | 0001564590-20-009541 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-06 | 2026-06-30 | 0001628280-26-053837 | EDGAR | 61K words |
| 2025-11-03 | 2025-09-30 | 0001628280-25-047919 | EDGAR | 63K words |
| 2025-08-07 | 2025-06-30 | 0001628280-25-038594 | EDGAR | 63K words |
| 2025-05-15 | 2025-03-31 | 0000950170-25-071991 | EDGAR | 64K words |
| 2024-11-04 | 2024-09-30 | 0000950170-24-120279 | EDGAR | 72K words |
| 2024-08-01 | 2024-06-30 | 0000950170-24-088951 | EDGAR | 72K words |
| 2024-05-13 | 2024-03-31 | 0000950170-24-058192 | EDGAR | 72K words |
| 2023-11-07 | 2023-09-30 | 0000950170-23-059764 | EDGAR | 75K words |
| 2023-08-04 | 2023-06-30 | 0000950170-23-038319 | EDGAR | 71K words |
| 2023-05-09 | 2023-03-31 | 0000950170-23-019132 | EDGAR | 69K words |
| 2022-11-08 | 2022-09-30 | 0000950170-22-022893 | EDGAR | — |
| 2022-08-08 | 2022-06-30 | 0001564590-22-028299 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-24 | 0001628280-26-058512 | EDGAR | 2K words |
| 2026-08-06 | 0001628280-26-053836 | EDGAR | 4K words |
| 2026-07-27 | 0001628280-26-049665 | EDGAR | 2K words |
| 2026-03-17 | 0001628280-26-018397 | EDGAR | 5K words |
| 2026-03-12 | 0001628280-26-017018 | EDGAR | 6K words |
| 2026-02-11 | 0001628280-26-007114 | EDGAR | 1K words |
| 2026-01-13 | 0001628280-26-001955 | EDGAR | 1K words |
| 2025-11-12 | 0001628280-25-051382 | EDGAR | 20K words |
| 2025-11-10 | 0001628280-25-051168 | EDGAR | 2K words |
| 2025-11-03 | 0001628280-25-047920 | EDGAR | 4K words |
169 total filings indexed. 140 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001357874 |
| Ticker | DTIL |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.precisionbiosciences.com |
| Listed | 2019-03-28 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/DTIL (~200 tokens, structured JSON with cryptographic provenance)